Evidence map›Paper›PMID 42125674›Full record

ReviewRadiologia brasileira

Breast cancer in women 40-50 and over 70 years of age: the need for screening in Brazil.

Ivie Braga de Paula, Luciano Fernandes Chala, Linei Augusta Brolini Delle Urban, Almir Galvão Vieira Bitencourt, Tatiane Mendes Gonçalves de Oliveira, Henrique Lima Couto, Paula de Camargo Moraes, Beatriz Medicis Maranhão Miranda, Thaís Paiva Moraes, Ana Claudia Mendes Rodrigues Mussauer and 9 more

Abstract readReview
In one paragraph

Review in Radiologia brasileira. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Ivie Braga de PaulaCasa Delas, Instituto Orizonti de Longevidade e Saúde, Belo Horizonte, MG, Brazil.ORCID 0000-0001-7040-6549
Luciano Fernandes ChalaGrupo Fleury Medicina e Saúde, São Paulo, SP, Brazil.ORCID 0000-0002-8469-4681
Linei Augusta Brolini Delle UrbanClínica de Diagnóstico Avançado por Imagem (DAPI), Curitiba, PR, Brazil.ORCID 0000-0002-4888-5413
Almir Galvão Vieira BitencourtA.C.Camargo Câncer Center, São Paulo, SP, Brazil.ORCID 0000-0003-0192-9885
Tatiane Mendes Gonçalves de OliveiraHospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da USP, Ribeirão Preto, SP, Brazil.ORCID 0000-0003-1291-2616
Henrique Lima CoutoRedimama-Redimasto, Belo Horizonte, MG, Brazil.ORCID 0000-0002-3789-4461
Paula de Camargo MoraesGrupo Dasa, São Paulo, SP, Brazil.ORCID 0009-0007-9134-6064
Beatriz Medicis Maranhão MirandaLucilo Maranhão Diagnósticos, Recife, PE, Brazil.ORCID 0000-0001-9085-2204
Thaís Paiva MoraesRedimama-Redimasto, Belo Horizonte, MG, Brazil.ORCID 0000-0003-1147-1783
Ana Claudia Mendes Rodrigues MussauerHospital São Vicente de Paulo, Rio de Janeiro, RJ, Brazil.ORCID 0009-0002-6578-1808
Ellyete de Oliveira CanellaCentro de Mama, Hospital Quinta D'Or, Rio de Janeiro, RJ, Brazil.ORCID 0000-0002-0600-9378
Selma di Pace BauabMama Imagem, São José do Rio Preto, SP, Brazil.ORCID 0000-0002-1296-2165
Ana Lucia Kefalás OliveiraSabin Medicina Diagnóstica, Uberaba, MG, Brazil.ORCID 0000-0002-5933-0130
José Luis Esteves FranciscoFaculdade de Medicina de São José do Rio Preto, São José do Rio Preto, Brazil.ORCID 0000-0002-1165-9762
Marcela Bisighelli SchaeferSONITEC Medicina Diagnóstica, Florianópolis, SC, Brazil.ORCID 0009-0003-5864-6664
Aline Dias Silva Guerrero GuimarãesGrupo Dasa, São Paulo, SP, Brazil.ORCID 0000-0003-4987-5580
Gustavo Machado BadanHospital Santa Catarina Paulista, São Paulo, SP, Brazil.ORCID 0000-0003-2037-3819
João Emílio PeixotoInstituto de Radioproteção e Dosimetria/CNEN, Rio de Janeiro, RJ, Brazil.ORCID 0000-0003-0689-3025
Rosangela Requi JakubiakClínica de Diagnóstico Avançado por Imagem (DAPI), Curitiba, PR, Brazil.ORCID 0000-0003-4258-6612

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is the most common malignancy among women in Brazil and the leading cause of cancer-related death in the female population of the country. Despite advances in treatment and the implementation of mammography screening programs, mortality rates have continued to rise. This increase is particularly evident among women under 50 years of age and those 70 years of age or older, groups that account for a substantial proportion of diagnosed cases and registered deaths in the country. Until recently, these age groups were not included in the screening guide-lines established by the Brazilian National Ministry of Health, although consistent scientific evidence demonstrates significant benefits of early detection in these populations, including reduced mortality, a higher proportion of early-stage diagnoses, and less aggressive therapeutic interventions. This article analyzes epidemiological data, the socio-economic impacts of breast cancer, and the scientific evidence regarding mammography screening, discussing the outcomes and limitations of national programs in Brazil. On the basis of that analysis, we advocate for the revision and expansion of public breast cancer screening policies to include women 40-49 and ≤ 70 years of age, as an essential strategy to reduce mortality, improve clinical outcomes, and promote greater equity in access to diagnosis and treat-ment of breast cancer in Brazil.

Indexed as

AgedBrazilBreast neoplasmsMammographyMass screeningMiddle aged

Identifiers

PMID42125674
PMCPMC13159457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.